MK Venture Capital is a fund of funds investment firm based in Munich, Germany, established in 2015. The firm specializes in investing in promising startups, focusing primarily on the software and mobile sectors. By leveraging a strategy that simplifies the investment process, MK Venture Capital aims to provide a low-risk approach to investing in emerging companies.
Reapplix A/S manufactures device for cell therapy that helps patients in wound healing. It offers 3C Patch, a triple layer patch that consists of fibrin for moisture retention and strength, platelets for growth factor release, and leucocytes to orchestrate wound healing and to fight infection. The company was formerly known as Reapplix ApS and changed its name to Reapplix A/S in December 2018. Reapplix A/S was founded in 2008 and is based in Birkerød, Denmark with an additional office in Southlake, Texas.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.